The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the Intuitive Surgical Inc stock forecast from 15 analysts, the average analyst target price for Intuitive Surgical Inc is USD 463.12 over the next 12 months. Intuitive Surgical Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Intuitive Surgical Inc is Slightly Bullish , which is based on 6 positive signals and 4 negative signals. At the last closing, Intuitive Surgical Inc’s stock price was USD 471.82. Intuitive Surgical Inc’s stock price has changed by -4.22% over the past week, +5.40% over the past month and +58.74% over the last year.
No recent analyst target price found for Intuitive Surgical Inc
No recent average analyst rating found for Intuitive Surgical Inc
Company Overview Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California. Read Less
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that ena...Read More
Frequently Asked Questions About Intuitive Surgical Inc (ISRG) Stock
Based on ratings from 15 analysts Intuitive Surgical Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 20 buy, sell and 5 hold ratings.
Unfortunately we do not have enough data on ISRG's stock to indicate if its a good dividend stock.
Based on targets from 15 analysts, the average taret price for ISRG is USD 463.12 over the next 12 months. The maximum analyst target price is USD 560 while the minimum anlayst target price is USD 375.
ISRG stock's Price/Earning ratio is 83.34.
Our analysis grades ISRG stock's Price / Earning ratio at F. This means that ISRG stock's Price/Earning ratio is above 75% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this ISRG may be a overvalued for its sector.
The last closing price of ISRG's stock was USD 471.82.
The most recent market capitalization for ISRG is USD 171.18B.
Based on targets from 15 analysts, the average taret price for ISRG is projected at USD 463.12 over the next 12 months.
This means that ISRG's stock price may go down by -1.84% over the next 12 months.
We can't find any ETFs which contains Intuitive Surgical Inc's stock.
As per our most recent records Intuitive Surgical Inc has 13,676 Employees.
Intuitive Surgical Inc's registered address is 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304.
You can get more information about it from Intuitive Surgical Inc's website at https://www.intuitive.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Intuitive Surgical Inc (ISRG) Stock
Based on ratings from 15 analysts Intuitive Surgical Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 20 buy, sell and 5 hold ratings.
Unfortunately we do not have enough data on ISRG's stock to indicate if its a good dividend stock.
Based on targets from 15 analysts, the average taret price for ISRG is USD 463.12 over the next 12 months. The maximum analyst target price is USD 560 while the minimum anlayst target price is USD 375.
ISRG stock's Price/Earning ratio is 83.34.
Our analysis grades ISRG stock's Price / Earning ratio at F. This means that ISRG stock's Price/Earning ratio is above 75% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this ISRG may be a overvalued for its sector.
The last closing price of ISRG's stock was USD 471.82.
The most recent market capitalization for ISRG is USD 171.18B.
Based on targets from 15 analysts, the average taret price for ISRG is projected at USD 463.12 over the next 12 months.
This means that ISRG's stock price may go down by -1.84% over the next 12 months.
We can't find any ETFs which contains Intuitive Surgical Inc's stock.
As per our most recent records Intuitive Surgical Inc has 13,676 Employees.
Intuitive Surgical Inc's registered address is 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304.
You can get more information about it from Intuitive Surgical Inc's website at https://www.intuitive.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ISRG !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
